Franz Stoiber

2-¹⁸fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET Trial

Maria De Santis, Alexander Becherer, Carsten Bokemeyer et al. · Journal of Clinical Oncology · 2004 · 424 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET–CT: a comparative study

Mohsen Beheshti, Reza Vali, Peter Waldenberger et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 275 citations

Medicine, Nuclear Medicine, Radiology +17

¹⁸F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients

Mohsen Beheshti, Larisa Imamovic, Gabriele Broinger et al. · Radiology · 2010 · 271 citations

Medicine, Nuclear Medicine, Oncology +17

Positron Emission Tomography/Computed Tomography with F-18-fluorocholine for Restaging of Prostate Cancer Patients: Meaningful at PSA < 5 ng/ml?

Martin Heinisch, Albert Dirisamer, Wolfgang Loidl et al. · Molecular Imaging and Biology · 2005 · 195 citations

Medicine, Nuclear Medicine, Oncology +14

2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial

M. Bachner, Yohann Loriot, Marine Gross‐Goupil et al. · Annals of Oncology · 2011 · 154 citations · Full text

Medicine, Nuclear Medicine, Oncology +17